Cardiovascular · 2025

FDA-cleared AI devices for cardiovascular 2025

2025 has 30 cardiovascular AI devices, 100% more than 2024 (15). That is 19.5% of the 154 cardiovascular devices on the FDA list, and 9% of all AI-device decisions dated 2025. The most active were Medicalgorithmics S.A. (2), Volta Medical (2), Abbott (1). The newest is eMurmur Heart AI from Csd Labs, decided on December 19, 2025.

302025 devices
28Companies
9%Of all 2025 AI devices
19.5%Of all cardiovascular

By month

Feb: 1Mar: 0Apr: 2May: 4Jun: 4Jul: 3Aug: 3Sep: 5Oct: 2Nov: 2Dec: 4
FebMarAprMayJunJulAugSepOctNovDec
Cardiovascular AI devices by month in 2025: Feb 1, Mar 0, Apr 2, May 4, Jun 4, Jul 3, Aug 3, Sep 5, Oct 2, Nov 2, Dec 4

All 30 devices

Frequently asked questions

How many FDA-cleared AI cardiovascular devices were there in 2025?

30 AI-enabled cardiovascular devices have a final decision dated 2025, from 28 companies.

How does 2025 compare with 2024 for AI cardiovascular devices?

2025 has 30 cardiovascular AI devices, 100% more than 2024 (15).

Which companies cleared the most AI cardiovascular devices in 2025?

Medicalgorithmics S.A. (2), Volta Medical (2), Abbott (1).

What was the most recent AI cardiovascular device in 2025?

eMurmur Heart AI from Csd Labs (K252284), decided on December 19, 2025. Product code DQD.

Which product codes were most common for AI cardiovascular devices in 2025?

DQK (Computer, Diagnostic, Programmable): 6; DQD (Stethoscope, Electronic): 3; QYE (Reduced Ejection Fraction Machine Learning-Based Notification Software): 3.

Cite as: AI Device Radar, “FDA-cleared AI devices for cardiovascular 2025,” https://ai-device-radar.vercel.app/specialty/cardiovascular/2025 (FDA list through 2026-06-29).